Overview

Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors

Status:
Unknown status
Trial end date:
2019-10-01
Target enrollment:
Participant gender:
Summary
Phase Ib/II study to evaluate the efficacy and tolerability of PM01183 in combination with olaparib in patients with advanced solid tumors.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Poveda, Andrés, M.D.
Collaborators:
AstraZeneca
PharmaMar
Treatments:
Olaparib